Related Experiment Video
Updated: Jul 20, 2026
09:29
An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
Published on: May 13, 2020
Effects of chronic amorphous silica exposure on sequential pulmonary function.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|June 1, 1979
Summary
Precipitated amorphous silica (PAS) exposure did not adversely affect lung function or cause pneumoconiosis in workers. Respiratory symptoms were linked to smoking, not silica exposure, indicating low occupational risk.
Area of Science:
- Occupational Health
- Pulmonary Medicine
- Materials Science
Background:
- Precipitated amorphous silica (PAS) is used in various industrial applications.
- Understanding the long-term respiratory effects of occupational PAS exposure is crucial for worker safety.
Purpose of the Study:
- To evaluate the clinical effects of long-term precipitated amorphous silica exposure on respiratory health in industrial workers.
Main Methods:
- Review of spirometry, respiratory questionnaires, and chest radiographs from 165 PAS-exposed workers.
- Calculation of cumulative exposure index (CEI) and mean exposure index (MEI).
- Linear regression analysis to assess correlations between exposure levels and pulmonary function changes.
Main Results:
- No adverse effects on pulmonary function variables (FVC, FEV1) were correlated with PAS exposure (CEI or years).
- Respiratory symptoms like cough and dyspnea correlated with smoking history, not PAS exposure.
- No radiographic evidence of pneumoconiosis was found in workers exposed solely to PAS.
Conclusions:
- Long-term occupational exposure to precipitated amorphous silica does not appear to cause significant adverse effects on lung function or lead to pneumoconiosis.
- Smoking remains a significant factor influencing respiratory symptoms in workers, independent of silica exposure.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...